BIOREM Inc.
BRM.V
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 48.74% | 19.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.74% | 19.86% | |||
| Cost of Revenue | 34.38% | 18.07% | |||
| Gross Profit | 85.41% | 24.72% | |||
| SG&A Expenses | 37.92% | 3.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.94% | 15.87% | |||
| Operating Income | 138.30% | 51.52% | |||
| Income Before Tax | 131.48% | 56.12% | |||
| Income Tax Expenses | 92.38% | 56.11% | |||
| Earnings from Continuing Operations | 145.57% | 56.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 145.57% | 56.12% | |||
| EBIT | 138.30% | 51.52% | |||
| EBITDA | 124.81% | 48.74% | |||
| EPS Basic | 164.38% | 56.25% | |||
| Normalized Basic EPS | 149.33% | 55.94% | |||
| EPS Diluted | 176.89% | 55.71% | |||
| Normalized Diluted EPS | 157.55% | 56.10% | |||
| Average Basic Shares Outstanding | -7.08% | -0.15% | |||
| Average Diluted Shares Outstanding | -10.19% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||